Krónikus limfoid leukémia (CLL): vizsgálatok itt: Egyesült Államok
184 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleNemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
- Where
- Buffalo
- Életkor
- 18 év and over
- People
- 32
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06863402 - 3. fázisTaking peopleA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Columbus, Fort Wayne, St. Petersburg, Tacoma, Westbrook
- Életkor
- 18 év and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - 1/2. fázisTaking peopleA Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Where
- Boston, Charlotte, Hackensack, Houston, La Jolla, New York, Rochester, Seattle, Winston-Salem
- Életkor
- 18 év and over
- People
- 174 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06542250 - 1/2. fázisNot yet taking people in Egyesült ÁllamokRoginolisib Plus Obinutuzumab + Venetoclax in R/R CLL
- Where
- Boston
- Életkor
- 18 év and over
- People
- 40
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07847957 - 3. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Where
- Baton Rouge, Birmingham, Boston, Chapel Hill, Charleston, Charlotte, Chicago, Dayton, Detroit, Durham, East Brunswick, Hackensack, Houston, Irvine, Jacksonville, La Crosse, La Jolla, Los Alamitos, Los Angeles, Miami, Nashville, Newark, New Orleans, New York, Oakland, Palestine, Palo Alto, Philadelphia, Phoenix, Roanake, Rochester, Roseville, San Francisco, Santa Clara, Seattle, Spokane, St Louis, Tacoma, Vallejo, Walnut Creek, Washington D.C., Waukee, Westwood, Winston-Salem
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06973187 · EU 2025-522860-34-00 - 3. fázisTaking peopleA Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
- Where
- Aurora, Boston, Charlotte, Chicago, Duarte, Durham, Eugene, Jacksonville, Miami, Milwaukee, New Orleans, New York, Omaha, Orange, Palo Alto, Pittsburgh, Rochester, Salt Lake City, Seattle, Tampa, Tyler, Zion
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT07277231 · EU 2025-524366-21-00 - 2. fázisTaking peoplePirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia
- Where
- Columbus
- Életkor
- 75 év and over
- People
- 50
- Run by
- Jennifer Woyach
See details and how to joinNCT07685717 - 2. fázisTaking peopleEarly Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Where
- Bethesda
- Életkor
- 18 év to 85 év
- People
- 75
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT03986034 - 4. fázisTaking peopleAcalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
- Where
- Charlotte, Columbus, Philadelphia
- Életkor
- 18 év to 130 év
- People
- 60 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06651970 - No phaseTaking peopleVaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
- Where
- Portland
- Életkor
- 18 év and over
- People
- 45
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT06784167 - 1. fázisTaking peopleZanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 23
- Run by
- City of Hope Medical Center
See details and how to joinNCT06735664 - 1. fázisCsak meghívásosCD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 15
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT07168486 - 2. fázisNot yet taking people in Egyesült ÁllamokDepletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
- Where
- Seattle
- People
- 52
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07819396 - 2. fázisTaking peopleAcalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Where
- Houston
- Életkor
- 18 év and over
- People
- 168
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04169737 - 2. fázisNot yet taking people in Egyesült ÁllamokZanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial
- Where
- Duarte, Irvine, Newnan
- Életkor
- 18 év and over
- People
- 44
- Run by
- City of Hope Medical Center
See details and how to joinNCT07812246 - 1. fázisTaking peopleRituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Where
- Cleveland
- Életkor
- 18 év and over
- People
- 15
- Run by
- Paolo Caimi, MD
See details and how to joinNCT07225439 - 1. fázisTaking peopleDose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Atlanta, Baltimore, Boston, Dallas, Milwaukee, Minneapolis, New York, Providence, Tampa
- Életkor
- 18 év and over
- People
- 135 worldwide
- Run by
- Imugene Limited
See details and how to joinNCT03666000 - 1. fázisTaking peopleTrivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
- Where
- Houston
- Életkor
- 12 hónap to 25 év
- People
- 38
- Run by
- Baylor College of Medicine
See details and how to joinNCT05010564 - 1/2. fázisTaking peopleStudy of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Where
- Birmingham, Boston, Chapel Hill, Dallas, Duarte, Goodyear, Greenville, Houston, Jacksonville, Lake Success, Morristown, Newnan, New Orleans, New York, Phoenix, Rochester, Scottsdale, Tampa, Zion
- Életkor
- 12 év and over
- People
- 160 worldwide
- Run by
- Sellas Life Sciences Group
See details and how to joinNCT04588922 - 3. fázisTaking peopleStudy of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
- Where
- Fairfax, Fort Wayne, Indianapolis, Macon, Midland, Nashville
- Életkor
- 18 év and over
- People
- 620
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT07516093 · EU 2025-524145-27-00 - 1. fázisTaking peopleEx Vivo Drug Sensitivity Testing and Multi-Omics Profiling
- Where
- Miami
- Életkor
- 1 nap to 21 év
- People
- 65
- Run by
- Florida International University
See details and how to joinNCT05857969 - No phaseTaking peopleA Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
- Where
- Akron, Albany, Ann Arbor, Atlanta, Augusta, Austin, Baltimore, Birmingham, Buffalo, Chapel Hill, Chicago, Cleveland, Columbia, Columbus, Dallas, Dayton, Detroit, Fargo, Fort Myers, Fort Worth, Grand Rapids, Greenville, Hackensack, Hollywood, Honolulu, Houston, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Madera, Madison, Marshfield, Memphis, Milwaukee, Minneapolis, Nashville, New Haven, Oakland, Oklahoma City, Omaha, Orlando, Pensacola, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Sacramento, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Spokane, St Louis, Tampa, The Bronx, Wilmington, Winston-Salem
- Életkor
- 6 év to 39 év
- People
- 330 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05702645 - 2. fázisTaking peopleCaloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Where
- Ann Arbor, Atlanta, Charlotte, Chicago, Cincinnati, Dallas, Denver, Houston, Kansas City, Los Angeles, Minneapolis, Orange, Philadelphia, Portland, Salt Lake City, San Francisco
- Életkor
- 7 év to 25 év
- People
- 240
- Run by
- Etan Orgel
See details and how to joinNCT05082519 - 3. fázisTaking peopleA Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Where
- Anaheim, Baton Rouge, Bethesda, Billings, Cerritos, Fort Myers, Greenville, Houston, Kingwood, Nashville, New Orleans, Palo Alto, Richmond, Saint Augustine, San Marcos, Spokane, West Palm Beach, York
- Életkor
- 18 év and over
- People
- 737 worldwide
- Run by
- Loxo Oncology, Inc.
See details and how to joinNCT05254743 · EU 2023-507699-38-00 - 2. fázisTaking peoplePhase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD
- Where
- Houston
- Életkor
- 18 év and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07566364